The largest epidemiological study to date on multidrug-resistant Klebsiella pneumoniae in Saudi hospitals highlights the need ...

The lingering effects of COVID-19 have driven an estimated 4,000 people out of New Hampshire’s workforce and led around 5,300 more to reduce their hours, according to a new study ...

A daily polypill was estimated to be cost-effective for primary CVD prevention among U.S. adults living in historically ...

Graft-Versus-Host disease market Insights. DelveInsight's Graft-Versus-Host Disease Market report offers an in-depth understanding of the epidemiology and ...

Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international ...

Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond, according to new research published today in Hypertension, a peer-reviewed journal of the ...

March 2024: Moleac Pte Ltd announced a study of Phase 4 clinical trials for NeuroAiD. SATURN investigates the promising role ...

DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment practices, mild cognitive impairment emerging drugs, market share of ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...

A new multi-institutional study led by King Abdullah University of Science and Technology (KAUST) and the Saudi Ministry of ...

The Centers for Disease Control and Prevention (CDC) has selected University of California San Diego as one of three partner ...

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...